タンパク質配列決定のアジア太平洋市場2020-2089

◆英語タイトル:ASIA PACIFIC PROTEIN SEQUENCING MARKET FORECAST 2020-2028
◆商品コード:INK20MY140
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:94
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe protein sequencing market of Asia Pacific is estimated to register the highest CAGR of 7.77% during the forecast period of 2020-2028. The remarkable developments in China and Japan for the incorporation of new technologies, and the progress of the healthcare sector, are the primary factors driving the market in the region.

REGIONAL INSIGHTS
The high growth rate of the Asia Pacific protein sequencing market is studied further by segregating the region into Japan, South Korea, Indonesia, Vietnam, China, Thailand, Australia & New Zealand, Thailand, and the rest of Asia Pacific that includes Malaysia, Singapore, and others. In Indonesia, the market is witnessing a steady growth due to the flourishing pharmaceutical industry. State driven developments and development in the private sector are stimulating impressive growth across the healthcare industry. The growing middle class and rising aging population in Indonesia and refurbishing of public health insurance contribute to the demand for healthcare services, leading to increased demands in the market. In countries like Thailand, the market is witnessing a steady growth due to developments in the biotech sector. Thailand is the center of many well-established pharma companies and world tech labs, and is ready to accept the new surge of advanced biotech development.
In Vietnam, the market is growing at a steady rate due to developments in the pharmaceutical sector. The growing status of Vietnam as a reliable junior partner with the US and other economically advanced countries can be transformed into an international start-up hub for long-term, complex ventures like biopharmaceutical development, which will supplement the market growth prospects of the region.

COMPETITIVE INSIGHTS
Shimadzu Corporation, Water Corporation, Agilent Technologies, Inc, Bruker Corp., and Thermo Fisher Scientific Inc, etc. are some of the leading companies functioning in the region.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with three years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key parts with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
3.3. KEY RESTRAINTS
3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY PRODUCT AND SERVICE
5.1. REAGENTS AND CONSUMABLES
5.2. INSTRUMENTS
5.2.1. EDMAN DEGRADATION
5.2.2. MASS SPECTROMETRY
5.3. ANALYSIS PRODUCT
5.4. PROTEIN SEQUENCING SERVICES
6. MARKET BY TECHNOLOGY
6.1. MASS SPECTROMETRY
6.2. EDMAN DEGRADATION
7. MARKET BY APPLICATION
7.1. ACADEMIA
7.2. BIOPHARMACEUTICALS
7.3. BIOTECHNOLOGY RESEARCH
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA PACIFIC
8.1.1. CHINA
8.1.2. JAPAN
8.1.3. INDIA
8.1.4. SOUTH KOREA
8.1.5. INDONESIA
8.1.6. THAILAND
8.1.7. VIETNAM
8.1.8. AUSTRALIA & NEW ZEALAND
8.1.9. REST OF ASIA PACIFIC
9. COMPANY PROFILES
9.1. SHIMADZU CORPORATION
9.2. AGILENT TECHNOLOGIES INC
9.3. THERMOFISHER SCIENTIFIC INC
9.4. PROTEOME FACTORY
9.5. WATER CORPORATION
9.6. BIOINFORMATICS SOLUTION
9.7. CHARLES RIVER LABORATORIES INC
9.8. SELVITA
9.9. RAPID NOVOR
9.10. SGS SA
9.11. BRUKER CORPORATION
9.12. TAKARA BIO



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[タンパク質配列決定のアジア太平洋市場2020-2089]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆